Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis
Clinical trial NCT04675242 · COMPLETED
Trial details
- NCT number
- NCT04675242
- Sponsor
- Nicox Ophthalmics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2021-06-16
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.